Skip to main content
Veterinary Medicines

Neomycinsulfat

Authorised
  • NEOMYCIN SULFATE

Product identification

Medicine name:
Neomycinsulfat
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Chicken (for reproduction)
  • Chicken (pullet)
  • Pig
  • Cattle (calf)
Route of administration:
  • In drinking water use
  • In-feed use
  • In drinking water/milk use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    1000.00
    gram(s)
    /
    1.00
    kilogram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (for reproduction)
      • Meat and offal
        7
        day
      • Egg
        0
        day
    • Chicken (pullet)
      • Meat and offal
        7
        day
    • Pig
      • Meat and offal
        14
        day
  • In-feed use
    • Chicken (for reproduction)
      • Meat and offal
        7
        day
      • Egg
        0
        day
    • Chicken (pullet)
      • Meat and offal
        7
        day
    • Pig
      • Meat and offal
        14
        day
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • BVL
Authorisation number:
  • 996.00.01
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."